MDA-MB-231-luc-D3H2LN: A Valuable Model for Triple-Negative Breast Cancer Research

Breast cancer is the most common non-skin cancer among women. One in eight women will develop invasive breast cancer during her lifetime, and about 10-20% of those women (more than one out of every 10) will be diagnosed with a triple-negative sub-type (ER-, PR- and HER2-). There is intense interest in developing new drugs that … Continue reading MDA-MB-231-luc-D3H2LN: A Valuable Model for Triple-Negative Breast Cancer Research